The European Commission has granted conditional marketing authorization for Pfizer’s Xalkori (crizotinib) to treat anaplastic lymphoma kinase (ALK)-positive advanced non-small cell lung cancer (NSCLC) in the European Union (EU). ...
Tags: Xalkori, crizotinib, anaplastic lymphoma kinase, ALK
Cytocell, a developer of fluorescence in situ hybridization (FISH) probes for use in cancer analysis, has unveiled a ROS1 Breakapart FISH probe test for non-small-cell lung cancer (NSCLC). The molecular cytogenetic test, which utilizes ...
Pfizer has received positive opinion from the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) for crizotinib to treat adults with previously treated anaplastic lymphoma kinase (ALK)-positive ...
Tags: Pfizer, CHMP, anaplastic lymphoma kinase
Ventana Medical Systems, a member of the Roche Group, has introduced a fully-automated staining technique, which helps researchers to examine miRNAs and proteins related to cancer in the same section of tumor tissue. Detecting miRNAs and ...
Tags: Ventana Medical Systems, miRNAs, proteins related to cancer
Diagnostic Biosystems (DBS) has launched the Mosaic 360 System with a product offering of novel Multiplex Immunohistochemistry kits and a complementary line of optimized IHC reagents. The company introduces a portfolio of five Mosaic ...
Abbott will expand the current CE-IVD product labeling for its Vysis ALK Break Apart FISH Probe Kit to allow the test to be marketed in the European Union as a companion diagnostic. The test uses Abbott's proprietary fluorescence in situ ...
Tags: Abbott, anaplastic lymphoma kinase, ALK, FISH technology
The Chinese-built Geely MK small car has been recalled in Australia after asbestos was found inside two of the vehicle's engine components. All three of Australia's cut-price Chinese passenger vehicle brands have now been involved in an ...
BioView and Abbott have entered into a partnership agreement for the development of automated scanning solution to detect rearrangements of the anaplastic lymphoma kinase (ALK) gene in patients with advanced non-small cell lung cancer ...
Tags: BioView, Abbott, automated scanning solution, NSCLC
Pfizer Canada has announced the availability of Xalkori (crizotinib) for patients with anaplastic lymphoma kinase (ALK)-positive advanced or metastatic non-small cell lung cancer (NSCLC) in Canada. A validated ALK assay should be used to ...
Tags: ALK, ALK-positive lung cancer, Pfizer Canada
The SFJ Pharmaceuticals Group (SFJ) has partnered with Pfizer to co-develop Dacomitinib as first-line treatment for patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) with activating mutations of epidermal ...
Tags: Cancer Drug, cell lung cancer, therapy
Eli Lilly and Company Alimta(pemetrexed for injection)has received FDA approval for new use in the continuation maintenance setting for advanced or metastatic nonsquamous non-small cell lung cancer(NS NSCLC). The approval was based on ...
Allegro Diagnostics has presented positive results from a clinical trial of its BronchoGen genomic test, designed for the early detection of lung cancer in current and former smokers. Using the company's PCR molecular testing platform ...
Tags: clinical trial, genomic test, Lung Cancer Detection Assay
Picomole patent paves way for breath analysis 13 Sep 2012 The company's infrared system for detecting signs of medical conditions in exhaled breath will soon receive US patent approval. Breath test Picomole,a developer of ...
The US Patent and Trademark Office (USPTO) has granted patent No. 8,232,262 to Ziopharm Oncology's palifosfamide (ZIO-201). The patent covers palifosfamide compositions, formulations, methods of use and methods of manufacture, which now ...
Tags: USPTO, patent, Palifosfamide, cancer treatment drug
Pentax Medical, a provider of endoscopic products and services, has introduced new EG-3270UK endoscope during the 30th GEEW congress in Brussels, Belgium. The new endoscope uses an instrument channel to deliver the optimal balance of a ...